Pediatric Hematology and Oncology Research Team | Research | Department of Pediatrics | UC Davis Health

Dr. Alvarez's research focuses on investigating factors that impact health outcomes in adolescent and young adult patients with cancer both in the United States and globally.

Publications:

• PubMed

Dr. Antony’s research interests are in pediatric neuro-oncology.

Publications:

• PubMed

Dr. Ducore's research interests include: epidemiology of childhood cancer including cancer in pediatric minority populations. The primary research at this time involves bleeding disorders including evaluation of global tests of coagulation and clinical trials of gene therapy for inherited bleeding disorders and the development of new products for the treatment of bleeding and clotting disorders. There is also an interest in the economic consequences of the arrival of newer therapies in the market for the treatment of bleeding disorders.

Publications:

• PubMed

Dr. Madden has interest in optimizing curative options for hemoglobinopathies, including gene editing, (CRISPR) technologies. She is also interested in optimizing the graft vs. malignancy effects in allogeneic transplant for leukemias and lymphomas. Further, she works on novel strategies for treating major transplant related complications, such as Graft vs. Host Disease (GVHD), and infection prevention.

Publications:

• PubMed

Dr. Malogolowkin's research interests are in pediatric solid tumors, developmental therapeutics, adolescent and young adults' cancer.

Publications:

• PubMed

Dr. Panigrahi’s research focuses on various conditions such as immune thrombocytopenic purpura and on hematological malignancies such as leukemia as well as HLH. He is also interested in clinical pharmacology and advancement through clinical trials. He is also involved in many aspects of medical education for both medical students and residents.

Publications:

• PubMed

Dr. Pawar's research focuses on leukemia, lymphoma, hemostasis and improving quality of life in pediatric hematology oncology patients. She is the institutional primary investigator for numerous international trials in hemostatic medications which will one day bring these innovative drugs to infants and younger children. She is also interested in machine learning and artificial intelligence as it applies to her area of expertise.

Publications:

• PubMed

Dr. Satake's research interests are in the characterization of leukemia stem cells in childhood leukemia.

Publications:

• PubMed